Notice Pursuant to the National Cooperative Research and Production Act of 1993-X12 Incorporated, 8113 [2019-04010]
Download as PDF
<![CDATA[
8113
Federal Register / Vol. 84, No. 44 / Wednesday, March 6, 2019 / Notices
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
finance, government, supply chain,
transportation and insurance industries
and associated business partners.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2019–04010 Filed 3–5–19; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—HEI Industry Group
By order of the Commission.
Issued: February 28, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019–03987 Filed 3–5–19; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—X12 Incorporated
Notice is hereby given that, on
February 11, 2019, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), X12
Incorporated (‘‘X12’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing (1) the name and
principal place of business of the
standards development organization
and (2) the nature and scope of its
standards development activities. The
notifications were filed for the purpose
of invoking the Act’s provisions limiting
the recovery of antitrust plaintiffs to
actual damages under specified
circumstances.
Pursuant to Section 6(b) of the Act,
the name and principal place of
business of the standards development
organization is: X12 Incorporated,
McClean, VA. The nature and scope of
X12’s standards development activities
are: The development and maintenance
of cross industry e-commerce standards
that improve business process
interoperability and facilitate business
information exchange supporting the
Notice is hereby given that, on
January 28, 2019, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), HEI
Industry Group (‘‘HIG’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
(1) the identities of the parties to the
venture and (2) the nature and
objectives of the venture. The
notifications were filed for the purpose
of invoking the Act’s provisions limiting
the recovery of antitrust plaintiffs to
actual damages under specified
circumstances.
Pursuant to Section 6(b) of the Act,
the identity of the parties to the venture
are: Chevron North America Exploration
and Production Company, a division of
Chevron U.S.A. Inc., Houston, TX;
ConocoPhillips Company, Houston, TX;
Exxon Mobil Corporation, Irving, TX;
Halliburton Energy Services, Inc.,
Houston, TX; Noble Energy, Inc.,
Houston TX, SWEPI LP (SWEPI),
Houston, TX; Schlumberger Technology
Corporation, Houston, TX; BHP,
Houston, TX; Statoil Gulf Services LLC,
Houston, TX; and Schlumberger
Limited, N.V., Houston, TX. The general
area of HIG’s planned activity is to
commence a joint industry-government
research initiative entitled HEI’s Energy
Research Program to (1) evaluate the
existing health and exposure literature
related to potential impacts from
onshore oil and natural gas operations;
and possibly (2) conduct a study to
assess potential exposures from those
operations. The industry sponsors have
created the HEI Industry Group (HIG) to
facilitate coordinated input to HEI. HEI
is a nonprofit organization chartered in
1980 as an independent research
institute to provide high-quality,
impartial, and relevant science on the
health effects of air pollution. The HEImanaged program represents a first-ofits-kind, comprehensive collaboration
between the oil and gas industry and
government to assess exposure to
chemical stressors associated with
onshore unconventional oil and natural
gas operations. Part 1 of the research
program will last for approximately one
year and will evaluate the existing
health and exposure literature as well as
conduct workshops to inform the
literature reviews and frame research
needs. Part 2 (an exposure study) is
being considered and will be informed
by the results of the Part 1 literature
review. If Part 2 goes forward, future
studies will be considered as warranted
by the Part 2 results.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2019–04009 Filed 3–5–19; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as an importer of
schedule I controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as an importer of scheduled I
controlled substances. Information on
the previously published notice is listed
in the table below. No comments or
objections were submitted and no
requests for hearing were submitted for
this notice.
SUMMARY:
Company
FR Docket
Agilent Technologies .............................................................
83 FR 66751 ........................................................................
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
VerDate Sep<11>2014
18:35 Mar 05, 2019
Jkt 247001
958(a) and determined that the
registration of the listed registrant to
import the applicable basic classes of
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Published
December 27, 2018.
schedule I controlled substances is
consistent with the public interest and
with United States obligations under
E:\FR\FM\06MRN1.SGM
06MRN1
]]>Agencies
[Federal Register Volume 84, Number 44 (Wednesday, March 6, 2019)]
[Notices]
[Page 8113]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04010]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--X12 Incorporated
Notice is hereby given that, on February 11, 2019, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), X12 Incorporated (``X12'')
has filed written notifications simultaneously with the Attorney
General and the Federal Trade Commission disclosing (1) the name and
principal place of business of the standards development organization
and (2) the nature and scope of its standards development activities.
The notifications were filed for the purpose of invoking the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances.
Pursuant to Section 6(b) of the Act, the name and principal place
of business of the standards development organization is: X12
Incorporated, McClean, VA. The nature and scope of X12's standards
development activities are: The development and maintenance of cross
industry e-commerce standards that improve business process
interoperability and facilitate business information exchange
supporting the finance, government, supply chain, transportation and
insurance industries and associated business partners.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2019-04010 Filed 3-5-19; 8:45 am]
BILLING CODE 4410-11-P
